Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse 16:00:02 2024-06-04 EDT 5-day change 1st Jan Change
360.9 USD -0.91% Intraday chart for Humana Inc. +3.34% -21.17%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Humana Expands Medicare Advantage Network in Alabama MT
Stephens Adjusts Humana Price Target to $400 From $350 MT
The University of Alabama At Birmingham Health System and Humana Sign Agreement, Expanding Humana's Medicare Advantage Provider Network in Alabama CI
Disaster averted Our Logo
ANALYST RECOMMENDATIONS : Humana, Netapp, Dell, Qualcomm, Paypal... Our Logo
Baird Initiates Humana at Neutral Rating With $374 Price Target MT
US health insurer shares fall after UnitedHealth flags Medicaid medical use RE
Sector Update: Health Care Stocks Retreat Wednesday Afternoon MT
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues RE
Health Insurance Stocks Drop as UnitedHealth Flags 'Disturbance' in Medicaid MT
Wolfe Research Raises Humana's Price Target to $400 From $373 MT
BofA Securities Adjusts Price Target on Humana to $376 From $342, Maintains Neutral Rating MT
Transcript : Humana Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
Humana Makes Jim Rechtin President, CEO MT
Humana Inc. Announces Executive Changes CI
Humana Inc. Announces CEO Changes CI
Cigna sees strong annual profit on lower costs, pharmacy benefit strength RE
Deutsche Bank Adjusts Price Target on Humana to $341 From $355 MT
HCA beats first-quarter profit estimates on higher patient admissions RE
UBS Cuts Humana's Price Target to $326 From $334, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on Humana to $365 From $381 MT
Goldman Sachs Adjusts Price Target on Humana to $373 From $385 MT
RBC Cuts Price Target on Humana to $353 From $415, Keeps Outperform Rating MT
Cantor Fitzgerald Adjusts Price Target on Humana to $360 From $391 MT
Oppenheimer Adjusts Price Target on Humana to $370 From $415 MT
Chart Humana Inc.
More charts
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
364.2 USD
Average target price
371.9 USD
Spread / Average Target
+2.10%
Consensus
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. News Humana Inc.
  5. Goldman Sachs Cuts Price Target on Humana to $385 From $450, Maintains Buy Rating